These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1331 related articles for article (PubMed ID: 26202627)

  • 1. Atrial fibrillation screening in pharmacies using an iPhone ECG: a qualitative review of implementation.
    Lowres N; Krass I; Neubeck L; Redfern J; McLachlan AJ; Bennett AA; Freedman SB
    Int J Clin Pharm; 2015 Dec; 37(6):1111-20. PubMed ID: 26202627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mixed methods analysis of community pharmacists' perspectives on delivering COPD screening service to guide future implementation.
    Fathima M; Saini B; Foster JM; Armour CL
    Res Social Adm Pharm; 2019 Jun; 15(6):662-672. PubMed ID: 30131254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study.
    Lowres N; Neubeck L; Salkeld G; Krass I; McLachlan AJ; Redfern J; Bennett AA; Briffa T; Bauman A; Martinez C; Wallenhorst C; Lau JK; Brieger DB; Sy RW; Freedman SB
    Thromb Haemost; 2014 Jun; 111(6):1167-76. PubMed ID: 24687081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A stakeholder co-design approach for developing a community pharmacy service to enhance screening and management of atrial fibrillation.
    Sabater-Hernández D; Tudball J; Ferguson C; Franco-Trigo L; Hossain LN; Benrimoj SI
    BMC Health Serv Res; 2018 Feb; 18(1):145. PubMed ID: 29486758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involving the public and other stakeholders in development and evaluation of a community pharmacy alcohol screening and brief advice service.
    Krska J; Mackridge AJ
    Public Health; 2014 Apr; 128(4):309-16. PubMed ID: 24713598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacists in general practice: a qualitative interview case study of stakeholders' experiences in a West London GP federation.
    Ryan K; Patel N; Lau WM; Abu-Elmagd H; Stretch G; Pinney H
    BMC Health Serv Res; 2018 Apr; 18(1):234. PubMed ID: 29609603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoting weight management services in community pharmacy: perspectives of the pharmacy team in Scotland.
    Weidmann AE; MacLure K; Marshall S; Gray G; Stewart D
    Int J Clin Pharm; 2015 Aug; 37(4):599-606. PubMed ID: 25822039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular disease risk screening by pharmacists: a behavior change wheel guided qualitative analysis.
    Almansour HA; Mekonnen AB; Aloudah NM; Alhawassi TM; Mc Namara K; Chaar B; Krass I; Saini B
    Res Social Adm Pharm; 2020 Feb; 16(2):149-159. PubMed ID: 31027964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the role of renal pharmacists in outpatient dialysis centres: a qualitative study.
    Salgado TM; Moles R; Benrimoj SI; Fernandez-Llimos F
    Int J Clin Pharm; 2012 Aug; 34(4):569-78. PubMed ID: 22538466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of diabetes screening in community pharmacy - factors influencing successful implementation.
    Siu AHY; Krass I; Mitchell B; McNamara K
    Res Social Adm Pharm; 2021 Sep; 17(9):1606-1613. PubMed ID: 33414090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacist health coaching in Australian community pharmacies: What do pharmacy professionals think?
    Singh HK; Kennedy GA; Stupans I
    Health Soc Care Community; 2020 Jul; 28(4):1190-1198. PubMed ID: 32020737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for atrial fibrillation during influenza vaccinations by primary care nurses using a smartphone electrocardiograph (iECG): A feasibility study.
    Orchard J; Lowres N; Freedman SB; Ladak L; Lee W; Zwar N; Peiris D; Kamaladasa Y; Li J; Neubeck L
    Eur J Prev Cardiol; 2016 Oct; 23(2 suppl):13-20. PubMed ID: 27892421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation.
    Wells KM; Thornley T; Boyd MJ; Boardman HF
    Res Social Adm Pharm; 2014; 10(1):58-71. PubMed ID: 23608701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of hypertension in an Australian community pharmacy setting - patients' beliefs and perspectives.
    Bajorek BV; LeMay KS; Magin PJ; Roberts C; Krass I; Armour CL
    Int J Pharm Pract; 2017 Aug; 25(4):263-273. PubMed ID: 27633151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacist and physician perspectives on diabetes service delivery within community pharmacies in Indonesia: a qualitative study.
    Wibowo Y; Sunderland B; Hughes J
    Int J Pharm Pract; 2016 May; 24(3):180-8. PubMed ID: 26670327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community pharmacy teams' experiences of general practice-based pharmacists: an exploratory qualitative study.
    Karampatakis GD; Patel N; Stretch G; Ryan K
    BMC Health Serv Res; 2020 May; 20(1):431. PubMed ID: 32423485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
    Mandt I; Horn AM; Ekedahl A; Granas AG
    Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examination of England's New Medicine Service (NMS) of complex health care interventions in community pharmacy.
    Latif A; Waring J; Watmough D; Barber N; Chuter A; Davies J; Salema NE; Boyd MJ; Elliott RA
    Res Social Adm Pharm; 2016; 12(6):966-989. PubMed ID: 26806858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 67.